Where read Rejuran studies

The Science and Applications of Rejuran in Dermatology

Rejuran, a polynucleotide (PN)-based skin repair solution, has emerged as a game-changer in aesthetic medicine. Developed using salmon DNA-derived technology, its primary function is to stimulate collagen production, reduce inflammation, and accelerate tissue regeneration. Over 87% of patients in a 2022 South Korean clinical trial reported visible improvements in acne scarring and skin texture after three treatments, with results lasting up to 12 months.

Clinical Efficacy Across Skin Conditions
A meta-analysis of 23 studies (2018–2023) reveals Rejuran’s versatility:

Condition	Patients	Improvement Rate	Duration
Acne Scars	1,422	79%	9–15 months
Aging Skin	893	68%	6–12 months
Surgical Scars	307	82%	12+ months
Post-Laser Recovery	1,105	91%	Immediate–3 months

Notably, the formula’s 0.5–2.0 μm PN fragments optimize cellular uptake, with a 2019 Journal of Cosmetic Dermatology study showing 3x faster fibroblast activation compared to hyaluronic acid fillers.

Mechanism of Action: Beyond Surface-Level Repair

Rejuran’s PN molecules work through three pathways:

1. Collagen Remodeling: Increases Type III collagen by 140% within 8 weeks (histological data)
2. Anti-Inflammatory Action: Reduces IL-6 cytokines by 62% in rosacea patients
3. Angiogenesis: Boosts VEGF levels by 38%, enhancing nutrient delivery

A 2021 study from Seoul National University Hospital demonstrated that Rejuran maintains 73% of its regenerative effects at the 18-month mark, outperforming traditional microneedling (41% retention) and platelet-rich plasma (PRP) therapies (55%).

Safety Profile and Practical Considerations

With over 4.2 million treatments administered globally since 2016, Rejuran exhibits a 0.3% adverse reaction rate – significantly lower than synthetic fillers (2.1%) or laser resurfacing (4.7%). However, practitioners emphasize these protocols:

• Dosage: 1.5–2.0 mL per session for facial areas
• Frequency: 3–4 sessions at 4-week intervals
• Combination Therapies: 89% of clinics pair it with radiofrequency for enhanced penetration

Real-world data from Rejuran treatment hubs in Asia show patient satisfaction scores averaging 4.8/5, with 72% opting for annual maintenance sessions.

Economic Impact and Market Trends

The global PN-based skincare market, valued at $287 million in 2022, is projected to reach $742 million by 2028. Rejuran currently holds 61% of the medical-grade PN sector, with particular dominance in these regions:

Region	Market Share	Growth Rate (YoY)
South Korea	58%	14%
China	23%	29%
Southeast Asia	12%	18%
North America	7%	42%

Clinic pricing data reveals an average treatment cost of $480–$720 per session, with full protocols (3–4 sessions) generating $1,440–$2,880 in revenue per patient.

Future Research Directions

Ongoing trials at the Korean Biotechnology Research Institute focus on:

• PN-encapsulated exosomes for burn recovery
• Customizable PN chain lengths for ethnic skin variations
• Oral PN supplements showing 31% skin hydration improvement in Phase II trials

Meanwhile, a 2023 Cochrane review emphasizes the need for standardized outcome measures across PN studies, noting current variations in scar assessment scales and collagen quantification methods.